Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia’s dual orexin receptor antagonist ...

Idorsia’s Quviviq (daridorexant) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), which means it is likely to be approved for use in around two months.

The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing "considerable ...

Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia's dual orexin receptor antagonist for the treatment of adults with chronic insomnia, will be presented a ...

Fox is particularly excited about three drugs called suvorexant, lemborexant and daridorexant, which have been approved by ...

(Curious how drugs are named? We’reobsessed with that too.) 2022: Daridorexant is approved by the FDA to be sold under the ...

Similarly, our preparations to commercialize daridorexant in Japan are progressing well in anticipation of a positive regulatory decision later this year. “In addition, throughout 2024 ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...